Investment Institute
Tecnología

How last year’s investment trends have evolved in 2024


A look at how the top investment trends of 2023, including AI, ESG, and health tech, are evolving in 2024 and what to anticipate with the U.S. election on the horizon.

As we look back at the top trends of 2023 – including AI, ESG, and health tech – it's clear that 2024 has brought both continuity and change. With the upcoming U.S. election adding an element of uncertainty, investors are navigating an evolving landscape.  

From a more discerning approach to AI investments to the growing significance of ESG and the resurgence of health tech, we delve into the changes underway in 2024 that long-term investors should watch.  


A more discerning investment landscape for AI 

After markets defied expectations in 2023, this year is seeing a continued “hot streak” for technology stocks, with the magnificent seven – Alphabet, Amazon, Apple, Meta, Microsoft, Nvidia, and Tesla – driving some 75% of this year’s S&P 500 gains.1  As the global digital transformation continues, a wealth of other innovative tech companies in areas like cloud computing, semiconductors, and cybersecurity appear to be well-positioned to further boost the overall tech sector. 

In 2023, AI burst onto the scene, spurring a round of massive investments while experts speculated how generative AI could change industries from robotics to e-commerce. Now we’re seeing more deliberate investments and decision-making from industry leaders, focused on deploying AI in its most promising business use cases. The 2024 Forbes AI 50 list includes companies using AI for defense tech, humanoid robots, healthcare, and much more.2 The age of AI is just beginning, and the long-term AI investment outlook may be promising, with the potential for generative AI to add $4.4 trillion of value annually to the global economy.3

  • QXhpb3MgKDYvMjEvMjAyNCk6IDxhIGhyZWY9Imh0dHBzOi8vd3d3LmF4aW9zLmNvbS8yMDI0LzA2LzIxL3RlY2gtYnVsbC1tYXJrZXQiPlRoZSB0ZWNoLWRyaXZlbiBidWxsIG1hcmtldDwvYT4=
  • Rm9yYmVzICg0LzExLzIwMjQpOiA8YSBocmVmPSJodHRwczovL3d3dy5mb3JiZXMuY29tL2xpc3RzL2FpNTAvIj5BSSA1MDwvYT4=
  • TWNLaW5zZXkgKDYvMTQvMjAyMSk6IDxhIGhyZWY9Imh0dHBzOi8vd3d3Lm1ja2luc2V5LmNvbS9jYXBhYmlsaXRpZXMvbWNraW5zZXktZGlnaXRhbC9vdXItaW5zaWdodHMvdGhlLWVjb25vbWljLXBvdGVudGlhbC1vZi1nZW5lcmF0aXZlLWFpLXRoZS1uZXh0LXByb2R1Y3Rpdml0eS1mcm9udGllciNpbnRyb2R1Y3Rpb24iPlRoZSBlY29ub21pYyBwb3RlbnRpYWwgb2YgZ2VuZXJhdGl2ZSBBSTogVGhlIG5leHQgcHJvZHVjdGl2aXR5IGZyb250aWVyPC9hPg==

As the energy transition continues, investors see a potentially compelling case for ESG

The United States continues to be a “hive of opportunity” for sustainable investing, with significant progress in areas like smart grids, battery energy storage systems (BESS), electrification, agricultural technology, resource management, and innovations in software and chip development.

Favorable policies and maturing technologies led to a 38% rise in investments in clean energy, transportation, electrification, and carbon management between 2022 and 2023, with $67 billion invested in the fourth quarter of 2023 alone.4  The Inflation Reduction Act and the CHIPS and Science Act were signed into law in August 2022 and continue to drive action among businesses and investors.

Today, ESG-driven “conscious investing” continues to offer investors potential ROI and greater protection from risks associated with poor corporate governance and climate change. Business practices are changing across industries, from sustainable fashion to sustainable travel and transportation, in response to policy and consumer demand. More companies are now calculating Scope 3 emissions, the indirect emissions occurring upstream or downstream of their operations, reflecting deeper ESG commitments. In March 2024, the U.S. SEC set new disclosure requirements for Scope 1 and 2 emissions (although these requirements are currently entangled in legal challenges).5

The impact of volatile weather patterns and power grid disruptions in 2023 highlighted the necessity for long-term green infrastructure investments, and the nationwide June 2024 heatwave again showed the need for reliable, resilient infrastructure investments. 

As 2024 continues, new energy challenges are emerging. Notably, the growth of AI is driving power demand and could account for 8% of total energy use in the U.S. by 2030,6  making the urgent case for investing in clean energy to support tech innovation. 

  • Q2xlYW4gSW52ZXN0bWVudCBNb25pdG9yICgyMDI0KTogPGEgaHJlZj0iaHR0cHM6Ly93d3cuY2xlYW5pbnZlc3RtZW50bW9uaXRvci5vcmcvIj5Ib21lPC9hPg==
  • Qmxvb21iZXJnIExhdyAoNi8yNC8yMDI0KTogPGEgaHJlZj0iaHR0cHM6Ly9uZXdzLmJsb29tYmVyZ2xhdy5jb20vZXNnL3MtcC01MDAtZmlybXMtcmFyZWx5LWRpc2Nsb3NlLWVtaXNzaW9ucy10by1zZWMtYXMtcnVsZXMtbG9vbSI+UyZhbXA7UCA1MDAgRmlybXMgUmFyZWx5IERpc2Nsb3NlIEVtaXNzaW9ucyB0byBTRUMgYXMgUnVsZXMgTG9vbTwvYT4=
  • V2FzaGluZ3RvbiBQb3N0ICg2LzIxLzIwMjQpOiA8YSBocmVmPSJodHRwczovL3d3dy53YXNoaW5ndG9ucG9zdC5jb20vYnVzaW5lc3MvMjAyNC8wNi8yMS9hcnRpZmljaWFsLWludGVsbGlnZW5jZS1udWNsZWFyLWZ1c2lvbi1jbGltYXRlLyI+QUkgaXMgZXhoYXVzdGluZyB0aGUgcG93ZXIgZ3JpZC4gVGVjaCBmaXJtcyBhcmUgc2Vla2luZyBhIG1pcmFjbGUgc29sdXRpb248L2E+

Tech innovations are fueling potential investor opportunities in health and biotech 

The biotech industry saw a wave of post-COVID investor caution in 2023, as funding dropped by 43.2% compared to 2022 and 52.3% compared to 2021.7  Yet 2023 saw a wave of technological innovation and consumer enthusiasm that is now fueling potential investor optimism in 2024 and beyond.

  • Alzheimer’s treatments. Late 2022 saw a breakthrough in Alzheimer’s drugs, with the first time any drug had consistently demonstrated success in slowing the disease’s progress.8  The FDA approved lecanemab in July 2023,9  and in June 2024 approved donanemab as well, leaving physicians, patients, and investors cautiously optimistic.10
  • AI technology. As AI technology continues to evolve in 2024, it could enable more accurate diagnostics, personalized treatments, better training, and greater operational efficiency, leading to investor opportunities.11
  • Weight loss treatments. GLP-1 agonist medications have proved highly popular – in fact, one in eight adults has tried a GLP-1 agonist.12  Drug companies currently have an additional 27 GLP-1 drugs in development, suggesting continued ROI.13
  • Gene therapy. In 2019, the FDA predicted it would be approving 10 to 20 cell and gene therapy products a year starting in 2025.14  At the end of 2023, the FDA approved Casgevy, the first FDA-approved treatment to utilize a type of novel genome editing technology.15  As of June 2024, there were over 35 gene therapies approved by the FDA, with at least 500 in line for assessment.16
  • Wearables.  U.S. consumers, especially older demographics, are turning to the latest in wearable wellness and personal health products, as AI technology continues to drive new product development in 2024. The U.S. fitness tracker market could see an 18.9% CAGR from 2023 to 2030.

Overall, the industry is likely to stabilize above pre-pandemic levels17  and continue growing in the years ahead.18  Investors could see significant returns as demand grows for innovative health tech solutions.

  • UGhhcm1hY2V1dGljYWwgVGVjaG5vbG9neSAoMy8xLzIwMjQpOiZuYnNwOzxhIGhyZWY9Imh0dHBzOi8vd3d3LnBoYXJtYWNldXRpY2FsLXRlY2hub2xvZ3kuY29tL2FuYWx5c3QtY29tbWVudC9iaW90ZWNoLWZ1bmRpbmctb3B0aW1pc20tcmlzZXMvIj5CaW90ZWNoIGZ1bmRpbmcgb3B0aW1pc20gcmlzZXMgYXMgNDQlIHByZWRpY3QgcmVjb3ZlcnkgaW4gMjAyNDwvYT4=
  • QmlvZ2VuICgxMS8zMC8yMDIyKTombmJzcDs8YSBocmVmPSJodHRwczovL3d3dy5laXNhaS5jb20vbmV3cy8yMDIyL25ld3MyMDIyODUuaHRtbCI+RWlzYWkgUHJlc2VudHMgRnVsbCBSZXN1bHRzIG9mIExlY2FuZW1hYiBQaGFzZSAzIENvbmZpcm1hdG9yeSBDbGFyaXR5IEFkIFN0dWR5IGZvciBFYXJseSBBbHpoZWltZXLigJlzIERpc2Vhc2UgQXQgQ2xpbmljYWwgVHJpYWxzIE9uIEFsemhlaW1lcuKAmXMgRGlzZWFzZSAoQ3RhZCkgQ29uZmVyZW5jZTwvYT4=
  • IEZEQSAoNy82LzIwMjMpOiZuYnNwOzxhIGhyZWY9Imh0dHBzOi8vd3d3LmZkYS5nb3YvbmV3cy1ldmVudHMvcHJlc3MtYW5ub3VuY2VtZW50cy9mZGEtY29udmVydHMtbm92ZWwtYWx6aGVpbWVycy1kaXNlYXNlLXRyZWF0bWVudC10cmFkaXRpb25hbC1hcHByb3ZhbCI+RkRBIENvbnZlcnRzIE5vdmVsIEFsemhlaW1lcuKAmXMgRGlzZWFzZSBUcmVhdG1lbnQgdG8gVHJhZGl0aW9uYWwgQXBwcm92YWw8L2E+
  • TllUaW1lcyAoNi8xMC8yMDI0KTombmJzcDtBIERydWcgdG8gU2xvdyBBbHpoZWltZXLigJlzIElzIEZpbmFsbHkgQXZhaWxhYmxlLiBIb3cgQXJlIFBhdGllbnRzIEZhcmluZz8=
  • TWVkVGVjaERpdmUgKDExLzIwLzIwMjMpOiZuYnNwOzxhIGhyZWY9Imh0dHBzOi8vd3d3Lm1lZHRlY2hkaXZlLmNvbS9wcmVzcy1yZWxlYXNlLzIwMjMxMTIwLTc3LW9mLWhlYWx0aGNhcmUtb3JnYW5pemF0aW9ucy1zdXJ2ZXllZC1oYXZlLWltcGxlbWVudGVkLXZpcnR1YWwtcmVhbGl0eS8iPjc3JSBvZiBIZWFsdGhjYXJlIE9yZ2FuaXphdGlvbnMgU3VydmV5ZWQgSGF2ZSBJbXBsZW1lbnRlZCBWaXJ0dWFsIFJlYWxpdHkgKFZSKSB0byBTdXBwb3J0IE1lZGljYWwgVHJhaW5pbmcg4oCTIG9yIGFyZSBQbGFubmluZyB0bzsgV2hhdCBhcmUgU29tZSBvZiB0aGUgVXNlIENhc2VzPzwvYT4=
  • S0ZGICg1LzEwLzIwMjQpOiZuYnNwO3todHRwczovL3d3dy5rZmYub3JnL2hlYWx0aC1jb3N0cy9wb2xsLWZpbmRpbmcva2ZmLWhlYWx0aC10cmFja2luZy1wb2xsLW1heS0yMDI0LXRoZS1wdWJsaWNzLXVzZS1hbmQtdmlld3Mtb2YtZ2xwLTEtZHJ1Z3MvIzp+OnRleHQ9QmxhY2slMjBhZHVsdHMlMjBhcmUlMjBzb21ld2hhdCUyMG1vcmUsT2Jlc2l0eSUyMERydWdzJTIwZm9yJTIwUmFjaWFsJTIwRGlzcGFyaXRpZXM/O0tGRiBIZWFsdGggVHJhY2tpbmcgUG9sbCBNYXkgMjAyNDogVGhlIFB1YmxpY+KAmXMgVXNlIGFuZCBWaWV3cyBvZiBHTFAtMSBEcnVnc30=
  • TkJDIE5ld3MgKDYvMjQvMjAyMyk6Jm5ic3A7PGEgaHJlZj0iaHR0cHM6Ly93d3cubmJjbmV3cy5jb20vaGVhbHRoL2hlYWx0aC1uZXdzL2JleW9uZC1vemVtcGljLWdscC0xLWRydWdzLXByb21pc2Utd2VpZ2h0LWxvc3MtaGVhbHRoLWJlbmVmaXRzLXJjbmExNTc1MjUiPkJleW9uZCBPemVtcGljOiBOZXcgR0xQLTEgZHJ1Z3MgcHJvbWlzZSB3ZWlnaHQgbG9zcyBhbmQgaGVhbHRoIGJlbmVmaXRzPC9hPg==
  • 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
  • RkRBICgxMi84LzIwMjMpOiZuYnNwOzxhIGhyZWY9Imh0dHBzOi8vd3d3LmZkYS5nb3YvbmV3cy1ldmVudHMvcHJlc3MtYW5ub3VuY2VtZW50cy9mZGEtYXBwcm92ZXMtZmlyc3QtZ2VuZS10aGVyYXBpZXMtdHJlYXQtcGF0aWVudHMtc2lja2xlLWNlbGwtZGlzZWFzZSI+RkRBIEFwcHJvdmVzIEZpcnN0IEdlbmUgVGhlcmFwaWVzIHRvIFRyZWF0IFBhdGllbnRzIHdpdGggU2lja2xlIENlbGwgRGlzZWFzZTwvYT4=
  • RkRBIChuLmQuKTombmJzcDs8YSBocmVmPSJodHRwczovL3d3dy5mZGEuZ292L3ZhY2NpbmVzLWJsb29kLWJpb2xvZ2ljcy9jZWxsdWxhci1nZW5lLXRoZXJhcHktcHJvZHVjdHMvYXBwcm92ZWQtY2VsbHVsYXItYW5kLWdlbmUtdGhlcmFweS1wcm9kdWN0cyI+QXBwcm92ZWQgQ2VsbHVsYXIgYW5kIEdlbmUgVGhlcmFweSBQcm9kdWN0czwvYT4=
  • TWNLaW5zZXkgKDIvNy8yMDI0KTombmJzcDs8YSBocmVmPSJodHRwczovL3d3dy5tY2tpbnNleS5jb20vaW5kdXN0cmllcy9saWZlLXNjaWVuY2VzL291ci1pbnNpZ2h0cy93aGF0LXRvLWV4cGVjdC1mcm9tLW1lZHRlY2gtaW4tMjAyNCI+V2hhdCB0byBleHBlY3QgZnJvbSBtZWR0ZWNoIGluIDIwMjQ8L2E+
  • RGVsb2l0dGUgKDMvMjcvMjAyMyk6Jm5ic3A7PGEgaHJlZj0iaHR0cHM6Ly93d3cyLmRlbG9pdHRlLmNvbS91cy9lbi9pbnNpZ2h0cy9pbmR1c3RyeS9oZWFsdGgtY2FyZS9oZWFsdGhjYXJlLXRlY2hub2xvZ3ktdHJlbmRzLmh0bWwiPkhlYWx0aCB0ZWNoIGludmVzdG1lbnQgdHJlbmRzOiBUZWNobm9sb2d5IGFuZCBwbGF0Zm9ybS1lbmFibGVkIGVjb3N5c3RlbXMgY291bGQgY2hhbmdlIGhlYWx0aCBjYXJlPC9hPg==

With the US election still to come, what should long-term investors keep in mind?

Election years always bring uncertainties. Yet long-term investors can look at market strengths and ongoing growth drivers that may warrant continued confidence in US opportunities.

The US economy grew over 9% between the end of 2020 and end of 2023,19  delivered above-average economic growth in 2023 despite the threat of recession, and the S&P 500, Dow Jones, and Nasdaq indices are showing continued momentum in 2024.20

The Biden administration enacted three policies in 2021 and 2022 – the Infrastructure Investment and Jobs Act, IRA, and CHIPS and Science Act – totaling around $1.5 trillion, based on AXA estimates, which created significant incentives for long-term investment. Since then, many U.S. firms have announced new projects, more than likely influenced by these policies.

While an administration change in November could undermine these policies, this could prove unlikely given the widespread popularity of these financial incentives and their existing economic impact.

The bottom line for long-term investors is that the U.S. economy is entering the election period in a strong position. 

  • Jm5ic3A7VS5TLiBCdXJlYXUgb2YgRWNvbm9taWMgQW5hbHlzaXMgKEJFQSkgKG4uZC4pOiZuYnNwOzxhIGhyZWY9Imh0dHBzOi8vd3d3LmJlYS5nb3YvZGF0YS9nZHAvZ3Jvc3MtZG9tZXN0aWMtcHJvZHVjdCI+R3Jvc3MgRG9tZXN0aWMgUHJvZHVjdCB8IFUuUy4gQnVyZWF1IG9mIEVjb25vbWljIEFuYWx5c2lzIChCRUEpPC9hPg==
  • RmFjdFNldCAoQXByaWwgMjAyNCk=

References to companies are for illustrative purposes only and should not be viewed as investment recommendations.

Risk Warning:

Investment involves risk including the loss of capital.

The information has been established on the basis of data, projections, forecasts, anticipations and hypothesis which are subjective. This analysis and conclusions are the expression of an opinion, based on available data at a specific date. Due to the subjective aspect of these analyses, the effective evolution of the economic variables and values of the financial markets could be significantly different for the projections, forecast, anticipations and hypothesis which are communicated in this material.

    Disclaimer

    This document is being provided for informational purposes only. The information contained herein is confidential and is intended solely for the person to which it has been delivered. It may not be reproduced or transmitted, in whole or in part, by any means, to third parties without the prior consent of the AXA Investment Managers US, Inc. (the “Adviser”).  This communication does not constitute on the part of AXA Investment Managers a solicitation or investment, legal or tax advice.   Due to its simplification, this document is partial and opinions, estimates and forecasts herein are subjective and subject to change without notice. There is no guarantee forecasts made will come to pass. Data, figures, declarations, analysis, predictions and other information in this document is provided based on our state of knowledge at the time of creation of this document. Whilst every care is taken, no representation or warranty (including liability towards third parties), express or implied, is made as to the accuracy, reliability or completeness of the information contained herein. Reliance upon information in this material is at the sole discretion of the recipient. This material does not contain sufficient information to support an investment decision.

    © 2024 AXA Investment Managers. All rights reserved.